Dr Dale Morrison receives the Lindsey Baudinet Rising Star Award
We would like to congratulate our postdoctoral researcher Dr Dale Morrison for receiving the Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research from the Australian Diabetes Society at the Australian Diabetes Congress 2024 conference for his study “Whey protein intervention to mitigate hypoglycaemia risk in people with type 1 diabetes”.
Hypoglycaemia is a significant issue for people living with type 1 diabetes (T1D). A key mechanism of hypoglycaemia in T1D is an impaired glucagon response which reduces the body’s ability to increase blood glucose. However, the glucagon response to ingestion of protein remains intact in T1D and we believe that rapidly-absorbing whey protein may represent an untapped utility for hypoglycaemia prevention. If successful, this would be clinically significant as whey protein is readily available, cost-effective, and largely free of side effects.
The aim of this study is to comprehensively characterize the magnitude and timing of the physiological glycaemic responses to whey protein ingestion in adults with T1D. Twelve adults with T1D will in random order ingest i) Water (control), ii) low-dose whey protein, iii) high-dose whey protein, iv) carbohydrate, under laboratory conditions with frequent blood sampling. Results will be used to inform further research using whey protein ingestion to prevent hypoglycaemia during exercise, overnight or periods of fasting (eg. Ramadan).
Dr Dale Morrison receives the Lindsey Baudinet Rising Star Award
We would like to congratulate our postdoctoral researcher Dr Dale Morrison for receiving the Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research from the Australian Diabetes Society at the Australian Diabetes Congress 2024 conference for his study “Whey protein intervention to mitigate hypoglycaemia risk in people with type 1 diabetes”.
Hypoglycaemia is a significant issue for people living with type 1 diabetes (T1D). A key mechanism of hypoglycaemia in T1D is an impaired glucagon response which reduces the body’s ability to increase blood glucose. However, the glucagon response to ingestion of protein remains intact in T1D and we believe that rapidly-absorbing whey protein may represent an untapped utility for hypoglycaemia prevention. If successful, this would be clinically significant as whey protein is readily available, cost-effective, and largely free of side effects.
The aim of this study is to comprehensively characterize the magnitude and timing of the physiological glycaemic responses to whey protein ingestion in adults with T1D. Twelve adults with T1D will in random order ingest i) Water (control), ii) low-dose whey protein, iii) high-dose whey protein, iv) carbohydrate, under laboratory conditions with frequent blood sampling. Results will be used to inform further research using whey protein ingestion to prevent hypoglycaemia during exercise, overnight or periods of fasting (eg. Ramadan).